About Adamas Pharma
Adamas Pharma is a company based in Emeryville (United States) founded in 2002 was acquired by Supernus Pharmaceuticals in October 2021.. Adamas Pharma has raised $68.03 million across 5 funding rounds from investors including Supernus Pharmaceuticals, HHS and Northgate Capital. The company has 142 employees as of December 31, 2021. Adamas Pharma offers products and services including QELBREE.
- Headquarter Emeryville, United States
- Employees 142 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adamas Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$68.03 M (USD)
in 5 rounds
-
Latest Funding Round
$1.25 M (USD), Grant
Jul 01, 2012
-
Investors
Supernus Pharmaceuticals
& 5 more
-
Employee Count
142
as on Dec 31, 2021
-
Acquired by
Supernus Pharmaceuticals
(Oct 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adamas Pharma
Adamas Pharma offers a comprehensive portfolio of products and services, including QELBREE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for treating central nervous system disorders with prescribing guidelines.
Unlock access to complete
Unlock access to complete
Sales and Marketing
160 people
Leadership Team
51 people
Product Management Team
14 people
Senior Team
14 people
Software Development Team
10 people
Operations Team
7 people
Finance and Accounting
7 people
Human Resources and Administration
5 people
Unlock access to complete
Funding Insights of Adamas Pharma
Adamas Pharma has successfully raised a total of $68.03M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $1.25 million completed in July 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $1.3M
-
First Round
First Round
(01 May 2005)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2012 | Amount | Grant - Adamas Pharma | Valuation |
investors |
|
| Aug, 2009 | Amount | Series D - Adamas Pharma | Valuation |
investors |
|
| Aug, 2007 | Amount | Series C - Adamas Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adamas Pharma
Adamas Pharma has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Supernus Pharmaceuticals, HHS and Northgate Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mid-stage venture capital investments and support for tech entrepreneurs.
|
Founded Year | Domain | Location | |
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Founded Year | Domain | Location | |
|
Northgate Capital is engaged in venture capital and private equity investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adamas Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adamas Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adamas Pharma Comparisons
Competitors of Adamas Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adamas Pharma
Frequently Asked Questions about Adamas Pharma
When was Adamas Pharma founded?
Adamas Pharma was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Where is Adamas Pharma located?
Adamas Pharma is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Who is the current CEO of Adamas Pharma?
Neil F. McFarlane is the current CEO of Adamas Pharma.
Is Adamas Pharma a funded company?
Adamas Pharma is a funded company, having raised a total of $68.03M across 5 funding rounds to date. The company's 1st funding round was a Series C of $13.09M, raised on May 01, 2005.
How many employees does Adamas Pharma have?
As of Dec 31, 2021, the latest employee count at Adamas Pharma is 142.
What does Adamas Pharma do?
Founded in 2002 and based in Emeryville, United States, Adamas Pharma operates as a specialty pharmaceutical company in the central nervous system (CNS) sector. Approved drugs pharmacokinetic profiles are enhanced to develop novel therapeutics, including fixed-dose combinations. The lead candidate, ADS-5102 (amantadine HCl extended-release), is evaluated for levodopa-induced dyskinesia in Parkinsons disease and walking impairment symptoms in multiple sclerosis.
What products or services does Adamas Pharma offer?
Adamas Pharma offers QELBREE.
Who are Adamas Pharma's investors?
Adamas Pharma has 6 investors. Key investors include Supernus Pharmaceuticals, HHS, Northgate Capital, Calibrium, and DAG Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.